Back to search
Schizophenia Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophenia Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophenia Disorder trials you may qualify forThis study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better t…
This longitudinal, observational study aims to assess whether the characteristics of a novel blood peripheral biomarker can serve as indicators for depression a…
The prevalence of smoking among people with schizophrenia (SCZ) is substantially higher at 54% to 90% (McClave et al., 2010). About half of all deaths amongst p…
This randomized clinical trial will test a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets so…
This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with…
The project proposes to develop a digital product based on cognitive behavioral therapy for the assisted treatment of depression. The digital cognitive behavior…
The goal of this study is to reduce Anticholinergic Medication (ACM) in persons with psychoses or serious mental illness, when these medications are no longer n…
This is a prospective observational study to identify sociodemographic factors that predict mental health outcomes in the European population and provide eviden…
The study protocol was submitted to ERA-NET NEURON for funding on 28/06/2023. Description of the Israeli responsibilities was extracted from the full submitted…